Pelvic Floor Distress Inventory (PFDI - 20): Difference between revisions
No edit summary |
No edit summary |
||
Line 36: | Line 36: | ||
The strength of the PFDI-20 is that it is a short form that gives a comprehensive assessment of the effect of pelvic floor disorders on the quality of life of women, rather than assessing just one aspect of pelvic floor function such as urinary incontinence. A more generic quality-of-life form as the SF-36 has demonstrated poor responsiveness in patients undergoing treatment for urinary incontinence. In these patient populations, it may be important to use both a generic quality-of-life instrument and a condition-specific instrument that has demonstrated responsiveness. The PFDI-20 is easy to use in both clinical and research settings.<ref name="Barber" /> | The strength of the PFDI-20 is that it is a short form that gives a comprehensive assessment of the effect of pelvic floor disorders on the quality of life of women, rather than assessing just one aspect of pelvic floor function such as urinary incontinence. A more generic quality-of-life form as the SF-36 has demonstrated poor responsiveness in patients undergoing treatment for urinary incontinence. In these patient populations, it may be important to use both a generic quality-of-life instrument and a condition-specific instrument that has demonstrated responsiveness. The PFDI-20 is easy to use in both clinical and research settings.<ref name="Barber" /> | ||
The MCID needs to be studied in larger populations.<ref name="Barber" /> | The MCID (clinically meaningful change in quality of life<ref name="crosby">Crosby RD, Kolotkin RL, Rhys Willisams G. Defining clinically | ||
meaningful change in health-related quality of life. J Clin | |||
Epidemiol 2003;56:395-407</ref>) needs to be studied in larger populations.<ref name="Barber" /> | |||
== Links == | == Links == |
Revision as of 10:34, 1 May 2014
Original Editor - Kirsten Ryan
Top Contributors - Kirsten Ryan, Admin, Laura Ritchie, Michelle Walsh, Tony Lowe, Kim Jackson, WikiSysop, Evan Thomas, Oyemi Sillo and Nicole Hills
Objective
[edit | edit source]
The PFDI-20 is both a symptom inventory and a measure of the degree of bother and distress (quality-of-life) caused by pelvic floor symptoms. It is a short-form version of the Pelvic Floor Distress Inventory.[1]
Intended Population
[edit | edit source]
Women with disorders of the pelvic floor including urinary incontinence, pelvic organ prolapse, and fecal incontinence.[1]
Method of Use[edit | edit source]
The PFDI-20 includes 20 questions and 3 scales. Each of the 3 scales is scored from 0 (least distress) to 100 (greatest distress). The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 - 300. The 3 scales include questions taken from the following widely used outcome measures: Urinary Distress Inventory - 6 questions, Pelvic Organ Prolapse Distress Inventory - 6 questions, and Colorectal-Anal Distress Inventory - 8 questions.[1]
Evidence[edit | edit source]
Reliability[edit | edit source]
The PFDI-20 has good test-retest reliability intraclass coefficient .86, P< .001. Each of the 3 scales (Urinary Distress Inventory, Pelvic Organ Prolapse Distress Inventory, and Colorectal-Anal Distress Inventory) demonstrates significant correlation with their long-form scales (r = .86, r = .92, and r = .93, respectively, P < .0001.[1]
Validity[edit | edit source]
The PFDI-20 demonstrates construct validity as it demonstrates a significant association with appropriate measures of symptom severity and pelvic floor diagnoses.[1]
Responsiveness[edit | edit source]
Each of the 3 scales of the PFDI-20 demonstrated moderate to excellent responsiveness with effect size and standardized response mean values ranging from .70 to 1.28. The sensitivity of the PFDI-20 as a whole was excellent with an effect size of 1.48 P < .0001 and standardized response mean of 1.09 P < .0001. The ability of the PFDI-20 to discriminate between subjects who indicated that they were "worse" after surgery from those who indicated they were "better" was excellent with c-statistic of .95.[1]
Miscellaneous
[edit | edit source]
The strength of the PFDI-20 is that it is a short form that gives a comprehensive assessment of the effect of pelvic floor disorders on the quality of life of women, rather than assessing just one aspect of pelvic floor function such as urinary incontinence. A more generic quality-of-life form as the SF-36 has demonstrated poor responsiveness in patients undergoing treatment for urinary incontinence. In these patient populations, it may be important to use both a generic quality-of-life instrument and a condition-specific instrument that has demonstrated responsiveness. The PFDI-20 is easy to use in both clinical and research settings.[1]
The MCID (clinically meaningful change in quality of life[2]) needs to be studied in larger populations.[1]
Links[edit | edit source]
Overview of PFDI-20 on the Rehabilitation Measures Database.
Link to the PFDI-20 on Beaumont Women's Health Center Website.
Paper by Barber et al 2005 describing the development of the PFIQ-7
Recent Related Research (from Pubmed)[edit | edit source]
Failed to load RSS feed from http://eutils.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=1ZU47V6mqjDOMOCqpXh69SgYWGtWDG-qhVgWzmgn9m9ODCFkAj|charset=UTF-8|short|max=10: Error parsing XML for RSS
References[edit | edit source]
References will automatically be added here, see adding references tutorial.
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 adn PFIQ-7). Am J Obstet Gynecol 2005;193:103-113. Cite error: Invalid
<ref>
tag; name "Barber" defined multiple times with different content - ↑ Crosby RD, Kolotkin RL, Rhys Willisams G. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003;56:395-407